Date Filed | Type | Description |
07/05/2023 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Sold 5,498 shares
@ $25.6466, valued at
$141k
|
|
05/19/2023 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Granted 1,256 shares
@ $16.9235, valued at
$21.3k
|
|
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/07/2022 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Granted 40,000 shares
@ $0 Granted 240,000 options to buy
@ $15.87, valued at
$3.8M
|
|
01/04/2022 |
4
| Peetz Christopher (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
11/29/2021 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Bought 7,000 shares
@ $14.4, valued at
$100.8k
|
|
10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/27/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2020 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Bought 3,000 shares
@ $18.76, valued at
$56.3k
Bought 2,000 shares
@ $18.6, valued at
$37.2k
|
|
11/12/2020 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Granted 1,371 shares
@ $15.266, valued at
$20.9k
|
|
01/14/2020 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Granted 170,000 options to buy
@ $19.24, valued at
$3.3M
|
|
01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/10/2019 |
4
| Peetz Christopher (President and CEO) has filed a Form 4 on Mirum Pharmaceuticals, Inc.
Txns:
| Bought 4,750 shares
@ $10.9065, valued at
$51.8k
Bought 2,000 shares
@ $10.9, valued at
$21.8k
Bought 2,320 shares
@ $11.35, valued at
$26.3k
|
|
07/17/2019 |
3
| Peetz Christopher (President and CEO) has filed a Form 3 on Mirum Pharmaceuticals, Inc. |
01/04/2019 |
4
| Peetz Christopher (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 7,650 options to buy
@ $0 |
|
04/24/2018 |
4
| Peetz Christopher (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 7,650 options to buy
@ $7.91, valued at
$60.5k
|
|
04/24/2018 |
3
| Peetz Christopher (Director) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
11/03/2016 |
4
| Peetz Christopher (CFO) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Disposed/sold 68,732 options to buy
@ $4.81, valued at
$330.6k
Disposed/sold 31,091 options to buy
@ $4.81, valued at
$149.5k
Disposed/sold 85,000 options to buy
@ $14, valued at
$1.2M
Disposed/sold 101,000 options to buy
@ $7.91, valued at
$798.9k
|
|